Clinical Pharmacology & Developmental Therapeutics Program
As one of the best new drug development programs in the country, our clinical pharmacologists are leaders in the development of new chemotherapy treatments for pediatric cancer.
It is a big step from the laboratory to the bedside, particularly when it comes to the discovery and testing of new cancer-fighting treatments. The development of more effective chemotherapy treatment for pediatric cancers requires a better understanding of the pharmacology of anti-cancer agents and the means by which tumors develop drug resistance.
The Developmental Therapeutics and Clinical Pharmacology Program at Texas Children's Cancer Center is associated with Baylor College of Medicine, one of the top medical schools in the country, and Texas Children's Hospital, the largest pediatric hospital in the United States.